Viewing StudyNCT01642082



Ignite Creation Date: 2024-05-06 @ 12:43 AM
Last Modification Date: 2024-10-26 @ 10:53 AM
Study NCT ID: NCT01642082
Status: COMPLETED
Last Update Posted: 2018-03-13
First Post: 2012-07-15

Brief Title: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
Sponsor: Gynecologic Oncology Group
Organization: GOG Foundation

Conditions & Keywords Data

Conditions:
Name
Endometrial Adenocarcinoma
Endometrial Clear Cell Adenocarcinoma
Endometrial Mixed Adenocarcinoma
Endometrial Mucinous Adenocarcinoma
Endometrial Serous Adenocarcinoma
Endometrial Squamous Cell Carcinoma
Endometrial Transitional Cell Carcinoma
Endometrial Undifferentiated Carcinoma
Recurrent Uterine Corpus Carcinoma
Keywords: